How Much Did Nusano Raise?
Funding & Key Investors

Nusano, a privately held physics company focused on the medical radioisotopes market, has secured $156M in total capital. The company recently announced a major strategic investment of $115M, underscoring its critical role in supply stability and innovation within this rapidly emerging sector. This latest financing round follows a Series A round in October 2018.

What is Nusano?

Nusano
ManufacturingChemicals & Related Products

Nusano operates within the specialized field of medical radioisotopes, addressing a critical need for supply stability and innovation. The company's commitment extends to serving industrial and commercial markets that depend on reliable access to high-quality radioisotopes for their products and services. By focusing on this niche yet vital market, Nusano positions itself as a key player in both healthcare and advanced material applications.

How much funding has Nusano raised?

Nusano has raised a total of $156M across 2 funding rounds:

2018

Series A

$41M

2024

Series C

$115M

Series A (2018): $41M, investors not publicly disclosed

Series C (2024): $115M led by The Wasatch Group, Verily, and S32

Key Investors in Nusano

The Wasatch Group

The Wasatch Group is an investment firm that has participated in Nusano's Series C funding round. Further details on their specific investment focus are not provided.

Verily

Verily, an Alphabet Inc. subsidiary, is a healthcare technology company focused on improving health outcomes through data-driven research and digital health solutions. Their investment in Nusano suggests a strategic interest in the intersection of advanced medical materials and data-driven health innovation.

S32

S32, also known as SISTEMA 32, specializes in integrated kitchens, wardrobes, and furniture, offering innovative design solutions. Their participation in Nusano's funding round indicates a potential diversification of their investment portfolio or a strategic alignment with companies driving innovation in critical supply chains.

What's next for Nusano?

The recent major strategic investment signifies a pivotal moment for Nusano, likely enabling significant expansion of its production capabilities and research and development initiatives. This infusion of capital is expected to bolster its efforts in achieving supply chain resilience for medical radioisotopes and potentially exploring new applications in industrial sectors. Nusano's trajectory suggests a move towards scaling operations and solidifying its market leadership in a field with substantial growth potential.

See full Nusano company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

ManufacturingMedical Devices & EquipmentDrug Stores & PharmaciesRetail
Building MaterialsManufacturingFinanceLending & BrokerageRetailFurnitureInsurance
ManufacturingTest & Measurement EquipmentArchitecture, Engineering & DesignConstructionIndustrial Machinery & EquipmentConstruction Management
ManufacturingToys & GamesRetail

Frequently Asked Questions Regarding Nusano Financial Insights

What are the most recent funding rounds that Nusano has completed, and what were the funding rounds?
Nusano has recently completed 2 funding rounds: Series C on Oct 1, 2024, Series A on Oct 24, 2018.
What is the total amount of funding Nusano has raised to date?
Nusano has raised a total of $156M in funding to date.
How many funding rounds has Nusano completed?
Nusano has completed 2 funding rounds.
How much funding did Nusano raise in its most recent funding round?
Nusano raised $115M in its most recent funding round.
Who are the lead investors in Nusano's latest funding round?
The lead investor in Nusano's latest funding round was The Wasatch Group. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Nusano's history?
The largest funding round in Nusano's history was $115M.
See more information about Nusano